Molecular rapid diagnostic testing for bloodstream infections: Nanopore targeted sequencing with pathogen-specific primers
Open Access
- 24 April 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 88 (6) , 106166
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Zhejiang Province Natural Science Foundation
This publication has 34 references indexed in Scilit:
- Application of Nanopore Sequencing in the Diagnosis and Treatment of Pulmonary InfectionsMolecular Diagnosis & Therapy, 2023
- Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS‐CoV‐2 and Other Respiratory VirusesSmall, 2021
- Rapid inference of antibiotic resistance and susceptibility by genomic neighbour typingNature Microbiology, 2020
- Bloodstream infections – Standard and progress in pathogen diagnosticsClinical Microbiology and Infection, 2020
- Sequencing-based methods and resources to study antimicrobial resistanceNature Reviews Genetics, 2019
- Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious diseaseNature Microbiology, 2019
- Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approachesClinical Microbiology and Infection, 2018
- Culture-Negative Severe SepsisChest, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2015